Metalkase Firebrick

Manufacturer: Harbison-Walker Refractories Company Product Category: Refractory brick Asbestos Type: Chrysotile asbestos Years Produced: 1946–1981 Legal Status: Tier 2 — Litigated Product

Product Description

Metalkase Firebrick was a refractory brick product manufactured by Harbison-Walker Refractories Company, one of the dominant producers of industrial refractory materials in the United States throughout much of the twentieth century. Refractory bricks are engineered to withstand extreme thermal conditions—sustained high temperatures, rapid thermal cycling, and direct contact with molten metals, slag, and superheated gases—that would destroy conventional masonry or structural materials.

Harbison-Walker supplied refractory products across a broad range of heavy industries, including steel manufacturing, foundry operations, glass production, cement kilns, petrochemical processing, and power generation. Metalkase Firebrick was part of the company’s industrial product line developed in the post-World War II era, positioned for applications in furnaces, kilns, boilers, and similar high-heat industrial installations where thermal stability and structural integrity under extreme conditions were essential requirements.

The product was manufactured and distributed from 1946 through 1981, a period that coincides with widespread industrial reliance on asbestos as a heat-resistant additive in construction and insulation materials. During these decades, asbestos was commonly incorporated into refractory and thermal products due to its well-documented resistance to heat, fire, and chemical degradation. Harbison-Walker was among the largest and most established names in the refractory industry during this period, supplying installations across the country to industrial facilities of varying scales and configurations.

Asbestos Content

Metalkase Firebrick contained chrysotile asbestos, the most commonly used form of asbestos in industrial manufacturing during the twentieth century. Chrysotile, sometimes referred to as white asbestos, is a serpentine mineral fiber that was widely incorporated into refractory and insulating products for its heat-resistant and binding properties.

In refractory brick formulations, asbestos fibers could serve multiple functional roles. They contributed to the thermal insulating properties of the finished product, helped stabilize the matrix of the brick under high-heat cycling conditions, and were compatible with other ceramic and mineral constituents used in refractory manufacturing. The inclusion of chrysotile in such products was consistent with broader industry practices during the mid-twentieth century, when asbestos was used extensively across manufacturing, construction, and industrial sectors.

Chrysotile asbestos is classified by the International Agency for Research on Cancer (IARC) as a Group 1 carcinogen—a substance with established causal links to human cancers, including mesothelioma, lung cancer, asbestosis, and other serious pulmonary diseases. Regulatory agencies, including OSHA and the EPA, have established that no safe level of occupational asbestos exposure has been identified. The long latency period associated with asbestos-related diseases—commonly ranging from 20 to 50 years between first exposure and clinical diagnosis—means that workers exposed to Metalkase Firebrick during its production years may be experiencing health consequences only now.

How Workers Were Exposed

Industrial workers in a variety of heavy-industry settings were potentially exposed to chrysotile asbestos fibers released from Metalkase Firebrick during normal installation, use, maintenance, and demolition activities across the product’s manufacturing lifespan.

Refractory bricks present multiple points of potential fiber release. During initial installation, workers cutting, grinding, or shaping bricks to fit furnace linings, kiln chambers, or other thermal enclosures could generate respirable asbestos-containing dust. Bricklayers and masons working in confined industrial spaces, where dust could accumulate and ventilation was often limited, faced sustained inhalation risks during these activities.

Once installed, refractory linings were subject to regular maintenance cycles. Furnaces, kilns, and boilers required periodic relining and repair, during which deteriorated or damaged brick was broken out and replaced. Workers involved in tearing out old refractory linings—a physically demanding process that generates significant airborne particulate—were exposed to dust from fractured and degraded bricks. In high-temperature applications, thermal degradation of the brick matrix over time could release bound asbestos fibers, compounding exposure risks during maintenance operations.

Demolition activities at industrial facilities at the end of a furnace’s service life represented another significant exposure scenario. Workers tasked with dismantling large-scale refractory installations had sustained contact with asbestos-containing dust and debris in conditions that often lacked modern respiratory protection protocols.

Beyond the primary trades involved in direct installation and removal, secondary exposure was a recognized risk. Industrial workers who performed tasks in proximity to refractory work—such as equipment operators, plant maintenance personnel, and laborers assigned to clean-up duties—could inhale fibers disturbed by nearby activity. Workers who laundered the clothing of those directly involved in refractory installation and removal were also at potential risk through secondary fiber transfer.

Prior to the regulatory actions of the 1970s, including OSHA’s initial asbestos standards promulgated under the Occupational Safety and Health Act of 1970 and subsequent amendments, many industrial worksites operated without adequate dust controls, respiratory protection requirements, or worker hazard disclosure. Workers handling asbestos-containing refractory products during this period frequently had limited or no awareness of the health hazards associated with fiber inhalation.

Documented Trust Fund / Legal Options

Harbison-Walker Refractories Company does not currently have an active asbestos bankruptcy trust fund established to compensate claimants exposed to its products. As a result, individuals diagnosed with asbestos-related illnesses following exposure to Metalkase Firebrick do not have access to a dedicated trust fund claims process tied to this manufacturer.

Litigation records document that Harbison-Walker and its successor entities have been named as defendants in asbestos personal injury litigation. Plaintiffs alleged that the company manufactured and distributed asbestos-containing refractory products, including firebrick, and that workers exposed to those products developed mesothelioma, lung cancer, asbestosis, and related conditions as a result. Plaintiffs alleged that Harbison-Walker knew or had reason to know of the hazards associated with asbestos-containing products and failed to adequately warn workers of those risks.

Industrial workers diagnosed with mesothelioma, lung cancer, asbestosis, or other asbestos-related diseases who have a documented history of occupational exposure to Metalkase Firebrick or other Harbison-Walker refractory products should consult with an attorney experienced in asbestos litigation. Legal counsel can evaluate the full exposure history to identify all potentially liable parties—including other manufacturers, premises owners, and co-defendants whose products may have been used at the same jobsites—and determine the most appropriate legal pathways available.

Because asbestos litigation involves complex questions of exposure history, product identification, and applicable statutes of limitations, early consultation is advisable. Exposure records, work history documentation, coworker testimony, and medical records all play important roles in establishing and supporting claims. Many asbestos attorneys handle these cases on a contingency fee basis, meaning no upfront legal costs are required.

This article is provided for informational purposes and documents facts established through litigation records, regulatory filings, and industry documentation. It does not constitute legal or medical advice. Individuals seeking guidance regarding asbestos exposure or related legal claims should consult qualified professionals.